Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

21.25 +0.00 (+0.02%)
Streaming Delayed Price Updated: 12:08 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Day One Biopharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Lam Research, D.R. Horton, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Analyst Expectations for Day One Biopharmaceutical's Future ↗
 
Via Benzinga
News headline image
What 8 Analyst Ratings Have To Say About Day One Biopharmaceutical ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Where Day One Biopharmaceutical Stands With Analysts ↗
 
Via Benzinga
What 7 Analyst Ratings Have To Say About Day One Biopharmaceutical ↗
 
Via Benzinga
News headline image
This Pediatric Cancer Company Makes It To Analyst's Conviction List ↗
 
Via Benzinga
News headline image
Insiders Buy Over $540M Of 2 Stocks ↗
Although the US stocks closed slightly lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗
 
Via Benzinga
News headline image
Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗
 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
News headline image
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday ↗
  WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests... 
Via Benzinga
News headline image
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
News headline image
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million. 
Via Benzinga
News headline image
Biotech ETF Tops in June: 5 Stocks That Outperform ↗
Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade ↗
Day One Biopharmaceuticals stock, which saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 83 to 92. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
DAWN Stock Is in the Spotlight as Day One Announces Common Stock Offering ↗
Day One Biopharmaceuticals (DAWN) stock is in the news Tuesday as a common stock offering has the company's shares moving. 
Via InvestorPlace
News headline image
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Piper Sandler reduced Braze, Inc. (NASDAQ: BRZE) price target from $65 to $42. Tesla shares rose 5.8% to $31.10 in pre-market trading. 
Via Benzinga
News headline image
93 Biggest Movers From Yesterday ↗
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping by more than 3% on Monday. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.